Vaccination for preventing postherpetic neuralgia (Q24235822)

Europe PubMed Central

title

Vaccination for preventing postherpetic neuralgia (English)

0 references

author name string

Ning Chen

1

0 references

Qifu Li

2

0 references

Yun Zhang

3

0 references

Muke Zhou

4

0 references

Dong Zhou

5

0 references

Li He

Cochrane Database of Systematic Reviews

6

0 references

publication date

16 March 2011

0 references

published in

0 references

cites work

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Kinetics and Viral Protein Specificity of the Cytotoxic T Lymphocyte Response in Healthy Adults Immunized with Live Attenuated Varicella Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

EFNS guidelines on pharmacological treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Corticosteroids for preventing postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

The Epidemiology of Varicella and Its Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

EFNS guidelines on neuropathic pain assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Clinical applications for change-point analysis of herpes zoster pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Treatment and prevention of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Clinical practice. Herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Topical lidocaine for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Antiviral treatment for preventing postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

What does epidemiology tell us about risk factors for herpes zoster?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Proposed classification of herpes zoster pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Immune response of elderly individuals to a live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007795.PUB2

7 January 2021